跳至主要内容
临床试验/CTRI/2025/10/096059
CTRI/2025/10/096059招募中3 期

Comparative Clinical Evaluation of Artificial-Intelligence & Neural Language-Models Assisted Prescription versus Conventional Repertory based Prescription in Homoeopathy Assessing Improvement in Patient Reported Outcomes: Single-Blind, Randomized, Exploratory, Pilot Study

Metropolitan Homoeopathic Medical College and Hospital1 个研究点 分布在 1 个国家目标入组 362 人开始时间: 2026年1月15日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
362
试验地点
1
主要终点
Outcome in Relation to Impact on Daily Living (ORIDL)

研究概览

简要总结

The findings of this pilot study could provide preliminary insights into the modernization of homoeopathic practice, education, and research. If AI-NLMs assisted prescribing demonstrates trends toward greater efficiency and effectiveness, it may suggest potential for reducing repertorization time, minimizing variability between prescribers, and enhancing patient outcomes. For students and early practitioners, AI-NLMs could serve as an exploratory educational aid, supporting their understanding of repertory and materia medica. Technologically, this trial would offer the first pilot-level systematic evidence on AI integration in homoeopathy, thereby laying the groundwork for larger, more definitive studies. At a broader level, the results may inform future discussions on the possible institutional and policy adoption of AI systems in homoeopathic hospitals, colleges, and research institutes, ultimately contributing to accessibility, credibility, and modernization of practice.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients of either sex, 18-65 years of age.
  • Patients seeking homoeopathic treatment.
  • Willingness to participate and provide written informed consent.

排除标准

  • Patients with immediate surgical emergency.
  • Self-declared and/or diagnosed severe uncontrolled systemic diseases such as advanced stage of malignancy, renal failure, decompensated cardiac disease and immune-compromised states.
  • Pregnant and lactating mother.
  • Patients requiring immediate conventional intervention.
  • Patient already under-goes homoeopathy treatment any illness.
  • Patients unwilling or unable to complete follow-up.
  • Patient with unstable mental condition.

结局指标

主要结局

Outcome in Relation to Impact on Daily Living (ORIDL)

时间窗: Baseline, After 4 weeks, After 8 weeks

次要结局

  • EuroQol Visual Analogue Scale (EQ-VAS)(Baseline, After 4 weeks, After 8 weeks)
  • Patient Global Impression of Change (PGIC)(Baseline, After 4 weeks, After 8 weeks)
  • Time taken for remedy selection (recorded in seconds by stopwatches)(Baseline)

研究者

发起方
Metropolitan Homoeopathic Medical College and Hospital
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Avidipta Hazra

Metropolitan Homoeopathic Medical College and Hospital

研究点 (1)

Loading locations...

相似试验